Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients

被引:4
作者
Pinto, Patricia [1 ]
Ghosh, Kanjaksha [1 ]
Shetty, Shrimati [1 ]
机构
[1] ICMR, Natl Inst Immunohaematol, Mumbai 400012, Maharashtra, India
关键词
FVIII inhibitors; F8; inversions; Haemophilia A; India; FACTOR-VIII INHIBITORS; GENE;
D O I
10.1016/j.bcmd.2014.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FVIII inhibitor development in haemophilia A (HA) patients, especially those with severe manifestations is a serious adverse effect in patients with haemophilia A, and the clinical management of these patients is very difficult as most don't respond to conventional treatment. Many genetic and non-genetic risk factors have been proposed however, these are diverse in different population groups, highlighting the importance of determining specific risk factors for each population. F8 mutations and especially inversions, which are the most common causative mutation in severe HA, have been significantly associated with inhibitor development earlier, however there is no conclusive data so far with regard to Indian haemophiliacs. This study provides novel evidence that intron 22 inversions in the F8 gene are indeed significantly associated with FVIII inhibitor development in Indian haemophiliacs. Further studies with other risk factors would enable better insights into the immune response towards FVIII in these patients, and possibly help to characterize patients at a higher risk for inhibitor development. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 163
页数:3
相关论文
共 40 条
  • [21] Incidence and treatment-related risk factors of inhibitor development after intensive FVIII replacement for major orthopaedic surgery in previous treated haemophilia A
    Wang, Han
    Zhu, Wei
    Wang, Shujie
    Feng, Bin
    Weng, Xisheng
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01):
  • [22] Detection of F8 mutations in carriers and patients with severe hemophilia A. Identification of a novel mutation
    Lopez-Vasquez, Lucia
    Albanez, Silvia
    Pestana, Carolina
    Porco, Antonietta
    INVESTIGACION CLINICA, 2016, 57 (04): : 377 - 387
  • [23] Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A A patient-level meta-analysis
    Marcucci, Maura
    Mancuso, Maria Elisa
    Santagostino, Elena
    Kenet, Gili
    Elalfy, Mohssen
    Holzhauer, Susanne
    Bidlingmaier, Christoph
    Ettingshausen, Carmen Escuriola
    Iorio, Alfonso
    Nowak-Goettl, Ulrike
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (05) : 958 - 967
  • [24] Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case-control study
    van Velzen, Alice S.
    Eckhardt, Corien L.
    Peters, Marjolein
    Oldenburg, Johannes
    Cnossen, Marjon
    Liesner, Ri
    Morfini, Massimo
    Castaman, Giancarlo
    McRae, Simon
    van der Bom, Johanna G.
    Fijnvandraat, Karin
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (06) : 1182 - 1191
  • [25] The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics
    Sauna, Zuben E.
    Lozier, Jay N.
    Kasper, Carol K.
    Yanover, Chen
    Nichols, Timothy
    Howard, Tom E.
    BLOOD, 2015, 125 (02) : 223 - 228
  • [26] Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients
    Lochan, A.
    Macaulay, S.
    Chen, W. C.
    Mahlangu, J. N.
    Krause, A.
    HAEMOPHILIA, 2014, 20 (05) : 687 - 692
  • [27] Identifying Nongenetic Risk Factors for Inhibitor Development in Severe Hemophilia A
    Gouw, Samantha C.
    Fijnvandraat, Karin
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (07) : 740 - 751
  • [28] Development of a Single-Tube Reverse Transcription Real-Time PCR Assay for Diagnosis of F8 Intron 22 Inversion in Patients and Carriers of Haemophilia A
    Arzuaga-Mendez, Javier
    Insunza, Lucia
    Ojinaga, Maria Jose
    Moreto, Ana
    Moreno-Gamiz, Maite
    Vara-Pampliega, Miriam
    Garcia-Ruiz, Juan Carlos
    Sierra-Aisa, Cristina
    HAEMOPHILIA, 2025, 31 (02) : 263 - 268
  • [29] An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan
    Shirahata, A.
    Fukutake, K.
    Higasa, S.
    Mimaya, J.
    Oka, T.
    Shima, M.
    Takamatsu, J.
    Taki, M.
    Taneichi, M.
    Yoshioka, A.
    HAEMOPHILIA, 2011, 17 (05) : 771 - 776
  • [30] Inverse Shifting-PCR Modified by Capillary Electrophoresis for Detecting F8 int22h and int1h Inversions in Severe Hemophilia A Patients and Probable Carriers
    Martinez-Contreras, Rosa Michel
    Garcia-Lopez, Silvia Sofia
    Luna-Zaizar, Hilda
    Jaloma-Cruz, Ana Rebeca
    LIFE-BASEL, 2024, 14 (10):